The ocular device spinout hopes to rapidly develop portable devices for eye testing powered by artificial intelligence software.
Aston Eyetech, a UK-based ocular device spinout from Aston University, has raised £5m ($6.6m) in series A funding from commercialisation firm Mercia Technologies and an undisclosed Asia-based investment syndicate.
Mercia contributed £1.8m to the funding round, acquiring a 19.4% stake in the company.
Founded in 2013, Aston Eyetech is building digital machines to monitor eye health for ophthalmological conditions. The artificial intelligence-powered devices are designed to be more portable than conventional models to help reach patients who are unable to…
